The only common aspect of these trials was that none could reproduce the highly significant preclinical improvements seen on cardiac function, nor could they demonstrate new cardiomyocyte generation.
← all excerpts
Stem cell therapies in cardiac diseases: Current status and future possibilities.
1
—
—